Avita Medical Limited, a regenerative medicine company focused on the treatment of wounds and skin defects, has filed an Inter Partes Review (IPR) petition against Renovacare patent. [ + ]

UK researchers have uncovered the secret behind the explosive leaping ability of leafhopper insects — a discovery that could help create better technology in the future. [ + ]

The Australian Clinical Trials Alliance has welcomed the funding commitment for clinical trials and registries in the Federal Budget. [ + ]

Australian epigenetics and genomics researcher Ryan Lister has been chosen alongside 40 researchers from 16 countries to receive a prestigious international scholarship that will fund his research. [ + ]

Pharmaceutical manufacturing and drug development company IDT Australia has received a Victorian Manufacturing Hall of Fame award in the High Growth Sector of Medical Technologies and Pharmaceuticals. [ + ]

Cannabis has the potential to reverse brain ageing and improve memory function, a new European study has revealed. [ + ]

Altnia Group has spun out a new company called Exopharm as part of its efforts to bring a new type of nanodrug called exosomes into local clinical trials. [ + ]

US scientists have solved a major conundrum regarding the exact role of a protein in a critical cancer-linked pathway. [ + ]

Microbiologist and honey expert Dr Nural Cokcetin has been named the country's best young science communicator at the Australian final of FameLab, an international competition sponsored by the British Council. [ + ]

PharmAust, an ASX-listed oncology company, has secured a key China patent. [ + ]

The Queensland Genomics Health Alliance (QGHA) has received funding for nine research projects as part of a $25 million initiative of the Palaszczuk government. [ + ]

In vitro diagnostics company EKF Diagnostics has expanded the distribution of its Procalcitonin LiquiColor test into Eastern Europe, the Middle East and APAC. [ + ]

With new gene-editing technology that overrides natural selection set to come into use in the next 3–5 years, the Australian Academy of Science claims it is time for Australia to have a national discussion about the implications of this technology. [ + ]

Genetic changes in acral and mucosal melanomas are completely different to the mutations found in skin melanoma, reveals a new study by Australian researchers. [ + ]

MTPConnect, the industry growth centre for the medical technology, biotechnology and pharmaceutical (MTP) sector, will open the second round of its $15.6 million Project Fund Program in July. [ + ]